Synlett 2023; 34(08): 931-936
DOI: 10.1055/a-1951-9897
letter
Special Issue Chemical Synthesis and Catalysis in India

Visible-Light-Mediated Organophotocatalyzed C(sp3)–H Activation and Intramolecular Cyclization

Krishna G. Ghosh
,
Koustav Pal
,
Debabrata Das
,
Palasetty Chandu
,
Devarajulu Sureshkumar
Financial support from IISER Kolkata (start-up grant), SERB (Early Career Research Award), and DST-SERB (Ramanujan Fellowship) are acknowledged. K.G.G., K.P., D.D., and P.C. thank DST, IISER-K, CSIR, and UGC for their Ph.D. fellowships.


Abstract

A metal-free approach for C(sp3)–H activation followed by an intramolecular Giese reaction to construct a wide range of cyclic ether scaffolds of various ring sizes under environmentally benign and straightforward conditions is reported. An easily prepared pyrylium salt is employed as an organophotocatalyst for this visible-light-driven, highly atom-economical (PMI = 64.34 g/g for a 0.2 mmol scale), cost-effective, and chemoselective transformation. The reported method has a broad functional-group tolerance, resulting in good-quality products. Furthermore, downstream functionalizations of a product and a gram-scale synthesis (PMI = 17.41 g/g for a 10 mmol scale) are demonstrated, highlighting our method’s advantages.

Supporting Information



Publication History

Received: 17 June 2022

Accepted after revision: 27 September 2022

Accepted Manuscript online:
28 September 2022

Article published online:
27 October 2022

© 2022. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References and Notes

    • 1a Stork G, Yamashita A, Adams J, Schulte GR, Chesworth R, Miyazaki Y, Farmer JJ. J. Am. Chem. Soc. 2009; 131: 11402
    • 1b Taylor RD, MacCoss M, Lawson AD. J. Med. Chem. 2014; 57: 5845
    • 1c Vitaku E, Smith DT, Njardarson JT. J. Med. Chem. 2014; 57: 10257
    • 2a Pang B, Qiao X, Janssen L, Velds A, Groothuis T, Kerkhoven R, Nieuwland M, Ovaa H, Rottenberg S, van Tellingen O, Janssen J, Huijgens P, Zwart W, Neefjes J. Nat. Commun. 2013; 4: 1908
    • 2b Paller CJ, Antonarakis ES. Drug Des. Dev. Ther. 2011; 5: 117
    • 2c Struthers A, Krum H, Williams GH. Clin. Cardiol. 2008; 31: 153
  • 3 Blunt JW. Copp B. R. Keyzers R. A, Munro MH. Prinsep M. R. Nat. Prod. Rep. 2016; 33: 382
  • 4 Hola E, Ortyl J. Eur. Polym. J. 2021; 150: 110365
    • 5a Tlili A, Lakhdar S. Angew. Chem. Int. Ed. 2021; 60: 19526
    • 5b Vega-Peñaloza A, Mateos J, Companyó X, Escudero-Casao M, Dell’Amico L. Angew. Chem. Int. Ed. 2021; 60: 1082
    • 5c White A, Wang L, Nicewicz D. Synlett 2019; 30: 827
    • 5d Zilate B, Fischer C, Sparr C. Chem. Commun. 2020; 56: 1767
    • 5e Joshi-Pangu A, Lévesque F, Roth HG, Oliver SF, Campeau L.-C, Nicewicz D, DiRocco DA. J. Org. Chem. 2016; 81: 7244
  • 6 Martiny M, Steckhan E, Esch T. Chem. Ber. 1993; 126: 1671
  • 7 Wilger DJ, Grandjean J.-MM, Lammert TR, Nicewicz DA. Nat. Chem. 2014; 6: 720
    • 8a Gesmundo NJ, Nicewicz DA. Beilstein J. Org. Chem. 2014; 10: 1272
    • 8b Perkowski AJ, Cruz CL, Nicewicz DA. J. Am. Chem. Soc. 2015; 137: 15684
    • 8c Kamata M, Murakami Y, Tamagawa Y, Kato M, Hasegawa E. Tetrahedron 1994; 50: 12821
    • 8d Maréchal D, Allonas X, Lecompère M, Criqui A. Macromol. Chem. Phys. 2016; 217: 1169
    • 8e Chandu P, Ghosh KG, Sureshkumar D. J. Org. Chem. 2019; 84: 8771
    • 8f Ghosh KG, Chandu P, Mondal S, Sureshkumar D. Tetrahedron 2019; 75: 4471
  • 9 Davies HM. L, Morton D. J. Org. Chem. 2016; 81: 343
    • 10a Ravelli D, Dondi D, Fagnoni M, Albini A. Chem. Soc. Rev. 2009; 38: 1999
    • 10b Capaldo L, Ravelli D. Eur. J. Org. Chem. 2017; 2017: 2056
    • 10c Uygur M, Mancheño OG. Org. Biomol. Chem. 2019; 17: 5475
    • 11a Beatty JW, Stephenson CR. J. Acc. Chem. Res. 2015; 48: 1474
    • 11b Fan X.-Z, Rong J.-W, Wu H.-L, Zhou Q, Deng H.-P, Tan JD, Xue C.-W, Wu L.-Z, Tao H.-R, Wu J. Angew. Chem. Int. Ed. 2018; 57: 8514
    • 11c Ruiz Espelt L, Wiensch EM, Yoon TP. J. Org. Chem. 2013; 78: 4107
    • 11d Ghosh KG, Das D, Chandu P, Sureshkumar D. J. Org. Chem. 2021; 86: 2644
  • 12 Liu J, Xie J, Zhu C. Org. Chem. Front. 2017; 4: 2433
  • 13 Substrates 1az; General Procedure All the substrates were prepared by following the previously reported method2 with the necessary modifications. An oven-dried, 100 mL, two-necked, round-bottomed flask equipped with a magnetic stirrer was charged with NaH (1.1 equiv) in anhyd THF (30 mL) under argon. 2,2-Dimethylpropane-1,3-diol (10 mmol, 1.0 equiv) was separately dissolved in anhyd THF (20 mL) and the solution was slowly added to the stirred solution of NaH at 0 °C. The mixture was allowed to warm to rt, then the appropriate benzyl bromide (1.2 equiv) was added dropwise with stirring and the reaction mixture was left overnight. Next, the reaction was quenched by dropwise addition of sat. aq NH4Cl (30 mL), and the organic layer was extracted with EtOAc (3 × 30 mL) and dried (Na2SO4) . The solvent was evaporated in a rotary evaporator, and the 3-(benzyloxy)-2,2-dimethylpropan-1-ol product was purified by flash column chromatography (silica gel). In the next step, the appropriate 3-(benzyloxy)-2,2-dimethylpropan-1-ol (1.0 equiv) and 100% Celite were added to a 100 mL round-bottomed flask equipped with a magnetic stirrer bar. PCC (1.2 equiv) and anhyd CH2Cl2 (50 mL) were then added under argon at room temperature. The mixture was stirred for 4 h and then filtered through a pad of Celite. The Celite bed was washed with CH2Cl2 (3 × 15 mL), and the filtrate was collected, washed successively with water, aq Na2CO3, and brine. The organic layer was dried (Na2SO4) and concentrated under a vacuum. The resulting crude product was purified by flash column chromatography to give the pure 3-(benzyloxy)-2,2-dimethylpropanal derivative. The final starting 2-[3-(benzyloxy)-2,2-dimethylpropylidene]malononitrile derivatives were obtained by the reaction between the appropriate 3-(benzyloxy)-2,2-dimethylpropanal (1.0 equiv) and malononitrile (1.1 equiv) in EtOH (30 mL) containing a catalytic amount of piperidine at rt with stirring. When the aldehyde was consumed (TLC), the solvent was removed in a rotary evaporator and the crude product was purified by flash column chromatography (silica gel). [3-(Benzyloxy)-2,2-dimethylpropylidene]malononitrile (1a) Colorless oil; yield 1.27 g (53%); Rf = 0.3 (silica gel, EtOAc–hexane, 0.5:9.5). 1H NMR (500 MHz, CDCl3): δ = 7.43–7.36 (m, 2 H), 7.33 (d, J = 9.9 Hz, 4 H), 4.55 (s, 2 H), 3.37 (s, 2 H), 1.33 (s, 6 H). 13C NMR (126 MHz, CDCl3): δ = 175.1, 137.5, 128.6, 128.0, 127.7, 113.2, 111.3, 88.1, 73.3, 41.3, 23.6.
  • 14 Cyclic Ethers 2av: General Procedure A oven-dried 20 mL reaction tube equipped with a magnetic stirrer bar was charged with the appropriate substrate 1 (0.2 mmol, 1 equiv) and PC-IV (0.01 mmol, 0.05 equiv) was added. The tube was evacuated for 5 min an then backfilled with N2; this cycle was repeated another four times before the tube was sealed with a rubber septum with a continuous flow of N2. Freshly dried CH2Cl2 (2 mL) and TFA (0.4 mmol, 2 equiv) were added through needles, and the tube was placed on a magnetic stirrer and irradiated by a Kessil 40 W, 456 nm blue LED, at a distance of ~3 cm. A cooling fan approximately 1 ft away was used to maintain the system at about rt. After 24 h, the tube was removed from the setup and the mixture was diluted sequentially with CH2Cl2 (5 mL) and brine (10 mL), then extracted with CH2Cl2 (3 × 20 mL). The combined organic layer was dried (Na2SO4) and the solvent was evaporated under reduced pressure. The crude product was purified by flash column chromatography [silica gel (230–400 mesh), EtOAc-hexane/CH2Cl2-hexane]. 2-(4,4-Dimethyl-2-phenyltetrahydrofuran-3-yl)malononitrile (2a) Colorless oil; yield: 42.8 mg (89%; dr = 1:1). Isomer 2a′: colorless oil; Rf = 0.3 (CH2Cl2/hexane, 3:7); 1H NMR (500 MHz, CDCl3): δ = 7.45–7.33 (m, 5 H), 4.86 (d, J = 9.1 Hz, 1 H), 3.95 (d, J = 8.8 Hz, 1 H), 3.82 (d, J = 8.7 Hz, 1 H), 3.74 (d, J = 5.6 Hz, 1 H), 2.25 (dd, J = 9.1, 5.7 Hz, 1 H), 1.38 (s, 3 H), 1.34 (s, 3 H). 13C NMR (126 MHz, CDCl3): δ = 139.0, 129.3, 129.2, 126.6, 111.8, 111.5, 84.1, 81.6, 56.3, 42.2, 27.3, 21.5, 20.8. Isomer 2a′′: colorless oil; Rf = 0.4 (CH2Cl2–hexane, 3:7); 1H NMR (500 MHz, CDCl3): δ = 7.52–7.32 (m, 5 H), 5.40 (d, J = 6.3 Hz, 1 H), 4.17 (d, J = 8.7 Hz, 1 H), 3.79 (d, J = 8.7 Hz, 1 H), 3.27 (d, J = 4.9 Hz, 1 H), 2.53 (dd, J = 6.1, 5.2 Hz, 1 H), 1.48 (s, 3 H), 1.42 (s, 3 H). 13C NMR (126 MHz, CDCl3): δ = 136.5, 129.3, 129.0, 126.7, 113.2, 112.4, 82.2, 80.0, 54.7, 42.9, 29.5, 22.2, 21.0. HRMS (ESI): m/z [M + Na]+ calcd for C15H16N2NaO: 263.1155; found: 263.1155.
  • 15 Zhou R, Liu H, Tao H, Yu X, Wu J. Chem. Sci. 2017; 8: 4654